IBD Spotlight is a recurring newsletter that highlights interesting, applicable and contemporary information to assist healthcare providers in the management of IBD.
2022 Spotlights
Malnutrition, estimated by GNRI (Generic Nutritional Risk Index) may represent a high risk in UC patients after age 65.
October 2022
The association of deficits in geriatric assessment, with disease activity and quality of life in older IBD patients.
October 2022
A novel tool to detect both peripheral and axial spondyloarthritis in patients with IBD.
September 2022
A systematic review and meta-analysis assessing the prevalence of Primary Sclerosing Cholangitis in patients with IBD
September 2022
Mesalazine non-adherence in pregnant UC patients may contribute to adverse pregnancy outcomes.
June 2022
A novel exclusion diet that may help induce remission in children with mild to moderate UC
May 2022
Predictors of long-term remission in children newly diagnosed with UC
May 2022
Feacal calprotectin (FC) home testing effective for predicting endoscopic activity in IBD
March 2022
Obesity may be associated with increased incidence of Crohn’s disease
February 2022
Several independent predictors for colorectal strictures identified for ulcerative colitis
February 2022
Repeated faecal microbial transfer may be associated with more favourable response and remission rates in IBD.
February 2022
A high incidence of VTE persists in patients with IBD, despite advances in treatment.
January 2022
Precision medicine in IBD is becoming a reality.
January 2022
2021 Spotlights
The Link Between Collagenous Colitis (CC) and Severe COVID-19 Infection Risk
June 2021
Potential Benefits of Mesalazine Treatment in Modulating Gut Microbiota
June 2021
IBD Patients and COVID-19 Infection Risk
May 2021
The Use of E-Medicine Systems in IBD Patient Care
May 2021
